Acquiring Company
Indivior Plc
Acquired Company
Supernus Pharmaceuticals
RockvilleBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Indivior Plc has proposed a merger with Supernus Pharmaceuticals, aiming to enhance its growth strategy and broaden its therapeutic offerings beyond opioid disorders. The deal is expected to result in a more diverse revenue stream and cost efficiencies. With a raised 2026 adjusted EBITDA outlook, Indivior positions itself for stronger profitability post-merger.
Don't miss Indivior Plc's next move
Get an email the moment Indivior Plc makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Supernus Pharmaceuticals?
Supernus Pharmaceuticals was acquired by Indivior Plc. The deal was reported on August 21, 2026. Indivior Plc is a pharmaceutical company focused on the treatment of substance use disorders. It develops and commercializes medicines that address medical needs in the field of addiction. Indivior Plc is publicly traded (INDV) and operates in Biotechnology.
When did Indivior Plc acquire Supernus Pharmaceuticals?
Indivior Plc's acquisition of Supernus Pharmaceuticals was reported on August 21, 2026. Indivior Plc has proposed a merger with Supernus Pharmaceuticals, aiming to enhance its growth strategy and broaden its therapeutic offerings beyond opioid disorders. The deal is expected to result in a more diverse revenue stream and cost efficiencies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Supernus Pharmaceuticals do?
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. It is publicly traded (SUPN), operating in Biotechnology, and is based in Rockville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.